Evaluation of vascular lesions using circulating endothelial cells in renal transplant patients

Clinical Transplantation

Volumn 26, Issue 4, 2012, Pages

  Wen, Jiqiu ^a   Chen, Jisong ^a   Ji, Shu Ming ^a   Cheng, Dongrui ^a   Liu, Zhi hong ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Acute rejection; C4d; Circulating endothelial cells; Kidney transplantation; Vascular lesions

Indexed keywords

COMPLEMENT COMPONENT C4D; HYALIN;

ACUTE GRAFT REJECTION; ACUTE KIDNEY TUBULE NECROSIS; ADULT; ARTICLE; BLOOD VESSEL INJURY; CHRONIC ALLOGRAFT NEPHROPATHY; CIRCULATING ENDOTHELIAL CELL; COMPLEMENT DEPOSITION; CONTROLLED STUDY; ENDARTERITIS; ENDOTHELIUM CELL; EVALUATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; KIDNEY ALLOGRAFT; KIDNEY PROXIMAL TUBULE; KIDNEY TRANSPLANTATION; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; VASCULAR LESION;

ADULT; ENDOTHELIUM, VASCULAR; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOMAGNETIC SEPARATION; KIDNEY; KIDNEY TRANSPLANTATION; MALE; PROGNOSIS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84864931551     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2012.01620.x     Document Type: Article

References (33)

1. Nankivell BJ, Chapman JR. Chronic allograft nephropathy: current concepts and future directions. Transplantation 2006: 81: 643.
2. Chapman JR, O'Connell PJ, Nankivell BJ. Chronic renal allograft dysfunction. J Am Soc Nephrol 2005: 16: 3015.
3. Satterwhite T, Chua MS, Hsieh SC et al. Increased expression of cytotoxic effector molecules: different interpretations for steroid-based and steroid-free immunosuppression. Pediatr Transplant 2003: 7: 53.
4. Simon T, Opelz G, Wiesel M, Süsal C, Ott R. Serial peripheral blood perforin and granzyme B gene expression measurements for prediction of acute rejection in kidney graft recipients. Am J Transplant 2003: 3: 1121.
5. Sarwal MM, Jani A, Chang S et al. Granulysin expression is a marker for acute rejection and steroid resistance in human renal transplantation. Hum Immunol, 2001: 62: 21.
6. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999: 55: 713.
7. Racusen LC, Colvin RB, Solez K et al. Antibody-mediated rejection criteria: an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant, 2003: 3: 708.
8. Bouvier CA, Gaynor E, Cintron JR et al. Circulating endothelium as an indication of vascular injury. Thromb Diath Haemorrh 1970: 40: 163.
9. Hladovec J, Rossmann P. Circulating endothelial cells isolated together with platelets and the experimental modification of their counts in rats. Thromb Res 1973: 3: 665.
10. Hladovec J. Circulating endothelial cells as a sign of vessel wall lesions. Physiol Bohemoslov 1978: 27: 140.
11. Vasa M, Fichtlscherer S, Aicher A et al. Number and migration activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001: 89: e1.
12. Griese DP, Ehsan A, Melo LG et al. Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy. Circulation 2003: 108: 2710.
13. Woywodt A, Bahlmann FH, de Groot K, Haller H, Haubitz M. Circulating endothelial cells: life, death, detachment and repair of the endothelial cell layer. Nephrol Dial Transplant 2002: 17: 1728.
14. Asahara T, Murohara T, Sullivan A et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997: 275: 964.
15. Takahashi T, Kalka C, Masuda H et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999: 5: 434.
16. Shi Q, Rafii S, Wu MH et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998: 92: 362.
17. Scott SM, Barth MG, Gaddy LR, Ahl EJ. The role of circulating cells in the healing of vascular prostheses. J Vasc Surg 1994: 19: 585.
18. Woywodt A, Streiber F, de Groot K, Regelsberger H, Haller H, Haubitz M. Circulating endothelial cells as markers for ANCA-associated small-vessel vasculitis. Lancet 2003: 361: 206.
19. Woywodt A, Schröder M, Mengel M et al. Circulating endothelial cells are a novel marker of cyclosporine-induced endothelial damage. Hypertension 2003: 41: 720.
20. Woywodt A, Schröder M, Gwinner W et al. Elevated numbers of circulating endothelial cells in renal transplant recipients. Transplantation 2003: 76: 1.
21. Koc M, Richards HB, Bihorac A, Ross EA, Schold JD, Segal MS. Circulating endothelial cells are associated with future vascular events in hemodialysis patients. Kidney Int 2005: 67: 1078.
22. Solez K, Colvin RB, Racusen LC et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant, 2008: 8: 753.
23. Mutin M, Canavy I, Blann A, Bory M, Sampol J, Dignat-George F. Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells. Blood 1999: 93: 2951.
24. Clancy R, Marder G, Martin V, Belmont HM, Abramson SB, Buyon J. Circulating activated endothelial cells in systemic lupus erythematosus: further evidence for diffuse vasculopathy. Arthritis Rheum 2001: 44: 1203.
25. Sowemimo-Coker SO, Meiselman HJ, Francis RB Jr. Increased circulating endothelial cells in sickle cell crisis. Am J Hematol 1989: 31: 263.
26. George F, Poncelet P, Laurent JC et al. Cytofluorometric detection of human endothelial cells in whole blood using S-Endo 1 monoclonal antibody. J Immunol Methods 1991: 139: 65.
27. Lagaaij EL, Cramer-Knijnenburg GF, van Kemenade FJ, Van Es LA, Bruijn JA, Van Krieken JH. Endothelial cell chimerism after renal transplantation and vascular rejection. Lancet 2001: 357: 33.
28. Mihatsch MJ, Kyo M, Morozumi K, Yamaguchi Y, Nickeleit V, Ryffel B. The side-effects of ciclosporine-A and tacrolimus. Clin Nephrol 1998: 49: 356.
29. Morozumi K, Takeda A, Uchida K, Mihatsch MJ. Cyclosporine nephrotoxicity: how does it affect renal allograft function and transplant morphology? Transpl Proc 2004: 36: S251.
30. Herzenberg AM, Gill JS, Djurdjev O, Magil AB. C4d deposition in acute rejection: an independent long-term prognostic factor. J Am Soc Nephrol 2002: 13: 234.
31. Feucht HE, Schneeberger H, Hillebrand G et al. Capillary deposition of C4d complement fragment and early graft loss. Kidney Int 2003: 43: 1333.
32. Kluth-Pepper B, Schneeberger H, Lederer SR, Albert E, Land W, Feucht HE. Impact of human alloreactivity on the survival of renal allografts. Transplant Proc 1998: 30: 1772.
33. Sun Q, Liu ZH, Cheng Z et al. Treatment of early mixed cellular and humoral renal allograft rejection with tacrolimus and mycophenolate mofetil. Kidney Int 2007: 71: 24.